MovDisordV3, France, Analysis, bibRecord, 000428

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

Identifieur interne : 000428 ( France/Analysis ); précédent : 000427; suivant : 000429

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

Auteurs : Frédéric Macia [France] ; Caroline Perlemoine [France] ; Irène Coman [France] ; Dominique Guehl [France] ; Pierre Burbaud [France] ; Emmanuel Cuny [France] ; Henri Gin [France] ; Vincent Rigalleau [France] ; François Tison [France]

Source :

Movement Disorders [ 0885-3185 ] ; 2004-02.

RBID : ISTEX:BA33C88BE28B4E0639853FCF96328D6CE8AF38C5

Descripteurs français

Pascal (Inist)
- Homme, Parkinson maladie, Prise poids, Système nerveux pathologie.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Body Composition (physiology), Body Mass Index, Combined Modality Therapy, Dominance, Cerebral (physiology), Dyskinesia, Drug-Induced (physiopathology), Dyskinesia, Drug-Induced (therapy), Electric Stimulation Therapy (adverse effects), Energy Metabolism (physiology), Female, Follow-Up Studies, Human, Humans, Levodopa (administration & dosage), Levodopa (adverse effects), Male, Middle Aged, Nervous system diseases, Parkinson Disease (physiopathology), Parkinson Disease (therapy), Parkinson disease, Parkinson's disease, Prospective Studies, Subthalamic Nucleus (physiopathology), Treatment Outcome, Weight Gain (physiology), Weight gain, deep brain stimulation, subthalamic nucleus, weight gain.
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , adverse effects : Antiparkinson Agents, Levodopa.
- adverse effects : Electric Stimulation Therapy.
- physiology : Body Composition, Dominance, Cerebral, Energy Metabolism, Weight Gain.
- physiopathology : Dyskinesia, Drug-Induced, Parkinson Disease, Subthalamic Nucleus.
- therapy : Dyskinesia, Drug-Induced, Parkinson Disease.
- Aged, Body Mass Index, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome.

Abstract

Weight, body mass index (BMI) and energy expenditure/energy intake (EE/EI) was studied in 19 Parkinson's disease (PD) patients after subthalamic deep brain stimulation (STN‐DBS) versus 14 nonoperated ones. Operated patients had a significant weight gain (WG, + 9.7 ± 7 kg) and BMI increase (+ 4.7 kg/m2). The fat mass was higher after STN‐DBS. Resting EE (REE; offdrug/ON stimulation) was significantly decreased in STN‐DBS patients, while their daily energy expenditure (DEI) was not significantly different. A significant correlation was found among WG, BMI increase, and pre‐operative levodopa‐equivalent daily dose, their reduction after STN‐DBS, and the differential REE related to stimulation and the REE in the offdrug/OFF stimulation condition. In conclusion, STN‐DBS in PD induces a significant WG associated with a reduction in REE without DEI adjustment. © 2003 Movement Disorder Society

Url:

https://api.istex.fr/document/BA33C88BE28B4E0639853FCF96328D6CE8AF38C5/fulltext/pdf

DOI: 10.1002/mds.10630

Affiliations:

Links to Exploration step

ISTEX:BA33C88BE28B4E0639853FCF96328D6CE8AF38C5

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight</title>
<author><name sortKey="Macia, Frederic" sort="Macia, Frederic" uniqKey="Macia F" first="Frédéric" last="Macia">Frédéric Macia</name>
</author>
<author><name sortKey="Perlemoine, Caroline" sort="Perlemoine, Caroline" uniqKey="Perlemoine C" first="Caroline" last="Perlemoine">Caroline Perlemoine</name>
</author>
<author><name sortKey="Coman, Irene" sort="Coman, Irene" uniqKey="Coman I" first="Irène" last="Coman">Irène Coman</name>
</author>
<author><name sortKey="Guehl, Dominique" sort="Guehl, Dominique" uniqKey="Guehl D" first="Dominique" last="Guehl">Dominique Guehl</name>
</author>
<author><name sortKey="Burbaud, Pierre" sort="Burbaud, Pierre" uniqKey="Burbaud P" first="Pierre" last="Burbaud">Pierre Burbaud</name>
</author>
<author><name sortKey="Cuny, Emmanuel" sort="Cuny, Emmanuel" uniqKey="Cuny E" first="Emmanuel" last="Cuny">Emmanuel Cuny</name>
</author>
<author><name sortKey="Gin, Henri" sort="Gin, Henri" uniqKey="Gin H" first="Henri" last="Gin">Henri Gin</name>
</author>
<author><name sortKey="Rigalleau, Vincent" sort="Rigalleau, Vincent" uniqKey="Rigalleau V" first="Vincent" last="Rigalleau">Vincent Rigalleau</name>
</author>
<author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BA33C88BE28B4E0639853FCF96328D6CE8AF38C5</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.10630</idno>
<idno type="url">https://api.istex.fr/document/BA33C88BE28B4E0639853FCF96328D6CE8AF38C5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001080</idno>
<idno type="wicri:Area/Istex/Curation">001080</idno>
<idno type="wicri:Area/Istex/Checkpoint">002608</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Macia F:parkinson:s:disease</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14978678</idno>
<idno type="wicri:Area/PubMed/Corpus">003549</idno>
<idno type="wicri:Area/PubMed/Curation">003549</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003378</idno>
<idno type="wicri:Area/Ncbi/Merge">000D35</idno>
<idno type="wicri:Area/Ncbi/Curation">000D35</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D35</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Macia F:parkinson:s:disease</idno>
<idno type="wicri:Area/Main/Merge">005585</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0365460</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002166</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B55</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002066</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Macia F:parkinson:s:disease</idno>
<idno type="wicri:Area/Main/Merge">005904</idno>
<idno type="wicri:Area/Main/Curation">003C27</idno>
<idno type="wicri:Area/Main/Exploration">003C27</idno>
<idno type="wicri:Area/France/Extraction">000428</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight</title>
<author><name sortKey="Macia, Frederic" sort="Macia, Frederic" uniqKey="Macia F" first="Frédéric" last="Macia">Frédéric Macia</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perlemoine, Caroline" sort="Perlemoine, Caroline" uniqKey="Perlemoine C" first="Caroline" last="Perlemoine">Caroline Perlemoine</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Diabétologie et Nutrition, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coman, Irene" sort="Coman, Irene" uniqKey="Coman I" first="Irène" last="Coman">Irène Coman</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guehl, Dominique" sort="Guehl, Dominique" uniqKey="Guehl D" first="Dominique" last="Guehl">Dominique Guehl</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Explorations Fonctionnelles du Système Nerveux, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Burbaud, Pierre" sort="Burbaud, Pierre" uniqKey="Burbaud P" first="Pierre" last="Burbaud">Pierre Burbaud</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Explorations Fonctionnelles du Système Nerveux, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cuny, Emmanuel" sort="Cuny, Emmanuel" uniqKey="Cuny E" first="Emmanuel" last="Cuny">Emmanuel Cuny</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurochirurgie B, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux</wicri:regionArea>
<placeName><settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gin, Henri" sort="Gin, Henri" uniqKey="Gin H" first="Henri" last="Gin">Henri Gin</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Diabétologie et Nutrition, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rigalleau, Vincent" sort="Rigalleau, Vincent" uniqKey="Rigalleau V" first="Vincent" last="Rigalleau">Vincent Rigalleau</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Diabétologie et Nutrition, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Hôpital Haut Lévèque, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-02">2004-02</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="206">206</biblScope>
<biblScope unit="page" to="212">212</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BA33C88BE28B4E0639853FCF96328D6CE8AF38C5</idno>
<idno type="DOI">10.1002/mds.10630</idno>
<idno type="ArticleID">MDS10630</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Body Composition (physiology)</term>
<term>Body Mass Index</term>
<term>Combined Modality Therapy</term>
<term>Dominance, Cerebral (physiology)</term>
<term>Dyskinesia, Drug-Induced (physiopathology)</term>
<term>Dyskinesia, Drug-Induced (therapy)</term>
<term>Electric Stimulation Therapy (adverse effects)</term>
<term>Energy Metabolism (physiology)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Prospective Studies</term>
<term>Subthalamic Nucleus (physiopathology)</term>
<term>Treatment Outcome</term>
<term>Weight Gain (physiology)</term>
<term>Weight gain</term>
<term>deep brain stimulation</term>
<term>subthalamic nucleus</term>
<term>weight gain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Electric Stimulation Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Body Composition</term>
<term>Dominance, Cerebral</term>
<term>Energy Metabolism</term>
<term>Weight Gain</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
<term>Subthalamic Nucleus</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Body Mass Index</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Parkinson maladie</term>
<term>Prise poids</term>
<term>Système nerveux pathologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Weight, body mass index (BMI) and energy expenditure/energy intake (EE/EI) was studied in 19 Parkinson's disease (PD) patients after subthalamic deep brain stimulation (STN‐DBS) versus 14 nonoperated ones. Operated patients had a significant weight gain (WG, + 9.7 ± 7 kg) and BMI increase (+ 4.7 kg/m2). The fat mass was higher after STN‐DBS. Resting EE (REE; offdrug/ON stimulation) was significantly decreased in STN‐DBS patients, while their daily energy expenditure (DEI) was not significantly different. A significant correlation was found among WG, BMI increase, and pre‐operative levodopa‐equivalent daily dose, their reduction after STN‐DBS, and the differential REE related to stimulation and the REE in the offdrug/OFF stimulation condition. In conclusion, STN‐DBS in PD induces a significant WG associated with a reduction in REE without DEI adjustment. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<settlement><li>Bordeaux</li>
</settlement>
</list>
<tree><country name="France"><noRegion><name sortKey="Macia, Frederic" sort="Macia, Frederic" uniqKey="Macia F" first="Frédéric" last="Macia">Frédéric Macia</name>
</noRegion>
<name sortKey="Burbaud, Pierre" sort="Burbaud, Pierre" uniqKey="Burbaud P" first="Pierre" last="Burbaud">Pierre Burbaud</name>
<name sortKey="Coman, Irene" sort="Coman, Irene" uniqKey="Coman I" first="Irène" last="Coman">Irène Coman</name>
<name sortKey="Cuny, Emmanuel" sort="Cuny, Emmanuel" uniqKey="Cuny E" first="Emmanuel" last="Cuny">Emmanuel Cuny</name>
<name sortKey="Gin, Henri" sort="Gin, Henri" uniqKey="Gin H" first="Henri" last="Gin">Henri Gin</name>
<name sortKey="Guehl, Dominique" sort="Guehl, Dominique" uniqKey="Guehl D" first="Dominique" last="Guehl">Dominique Guehl</name>
<name sortKey="Perlemoine, Caroline" sort="Perlemoine, Caroline" uniqKey="Perlemoine C" first="Caroline" last="Perlemoine">Caroline Perlemoine</name>
<name sortKey="Rigalleau, Vincent" sort="Rigalleau, Vincent" uniqKey="Rigalleau V" first="Vincent" last="Rigalleau">Vincent Rigalleau</name>
<name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000428 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000428 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:BA33C88BE28B4E0639853FCF96328D6CE8AF38C5
   |texte=   Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.